Typicality: | 0.413 |
Saliency: | 0.381 |
between the 2017 hypertension canada | 4 | location |
in the second study | 4 | location |
between imipenem | 3 | other |
colleague → examine → difference | 6 |
colleague → explore → difference | 4 |
colleague → investigate → difference | 3 |
colleague → examine → the difference | 3 |
negative | neutral | positive |
0.050 | 0.779 | 0.171 |
Raw frequency | 16 |
Normalized frequency | 0.381 |
Modifier score | 0.500 |
Perplexity | 477.647 |